2Andre T,Bensmaine MA,Louvet C,et al.Multicenter,phase Ⅱ study of bimonthly high-dose leucovorin,fluorouracil infudion,and oxaliplatin for metastatic colorectal cancer resisitant to the same leucovorin and fluorouracil regimen.J.Clin.Oncol.,1999,17(11):3560-3568.
3De Gramont A,Tournigand C,Louvet C,et al.Oxaliplatin folinicacid and 5-fluorouracil(folflox) in pretreated patients with metastatic advanced cancer[J].Rev.Med.Int,1997,18(10):769-775.
4Bismuth H,Adam R,Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy[J],Semin Oncol,1998,25(2 Suppl 5):40-46.
4[3]DillmanRO,HemdonJ,SearrenSL,et al.Improved survival in stage 3 non -small cell lung cancer.seven-year follow-up of cancer and leudemia group B (CALGB)8433 trial[J].J Natal Cancer Inst,1996,88(17):1210-1216.
5Borner MM, Castiglione M, Bacchi M, et al. The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma:results of a phase Ⅲ trial.Swiss Group of for clinical Cancer Research (SAKK)[J].Ann Ocol, 1998,9(5):535-541.
6周际昌．实用肿瘤内科学[M]．第1版．北京：人民卫生出版社，1998：205-297．
7Dillman RO, Herndon J, Searren SL, et al . Improved survival in stage 3 non- small cell lung cancer:seven year follow- up of cancer and leudemia group B(CALGB) 8 433 trial [J].J Natal Cancer Inst, 1996,88(17):1 210-1 216.
8贾博琦，鲁云兰．现代临床使用药物手册[M]．第2版．北京：北京医科大学出版社，2001：2．
9贾博琦.现代临床使用药物手册[M].2版.北京:北京医科大学出版社,2001:21.
10Xiao J,Cai Z,Li W,et al.Tumor Volume Reduction Rate Predicts Pathologic Tumor Response of Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy alone:Results from a Prospective Trial[J].J Cancer,2015,6(7):636-642.
